XML 63 R51.htm IDEA: XBRL DOCUMENT v3.24.2.u1
REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION - Schedule of Disaggregation of Total Net Product Revenues by Product (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue from External Customer [Line Items]        
Revenue $ 712,029 $ 595,275 $ 1,360,862 $ 1,191,690
Product        
Revenue from External Customer [Line Items]        
Revenue 702,129 584,698 1,339,944 1,171,124
VOXZOGO        
Revenue from External Customer [Line Items]        
Revenue 183,923 113,337 336,812 201,173
VIMIZIM        
Revenue from External Customer [Line Items]        
Revenue 178,016 177,392 370,536 366,584
NAGLAZYME        
Revenue from External Customer [Line Items]        
Revenue 132,049 90,103 237,678 213,124
PALYNZIQ        
Revenue from External Customer [Line Items]        
Revenue 88,291 74,868 164,000 137,220
BRINEURA        
Revenue from External Customer [Line Items]        
Revenue 45,309 38,058 84,356 77,202
ALDURAZYME        
Revenue from External Customer [Line Items]        
Revenue 38,558 40,318 73,820 74,721
KUVAN        
Revenue from External Customer [Line Items]        
Revenue 28,551 50,622 64,461 101,100
ROCTAVIAN        
Revenue from External Customer [Line Items]        
Revenue 7,432 0 8,281 0
Royalty and other revenues        
Revenue from External Customer [Line Items]        
Revenue $ 9,900 $ 10,577 $ 20,918 $ 20,566